Choa Pharmaceutical Co., Ltd. (034940)

Overview

ChoA Pharmaceutical Co., Ltd., established in 1964 and headquartered in Seoul, South Korea, is a leading pharmaceutical company that has carved a niche in the healthcare industry both domestically and internationally. With a robust portfolio of approximately 200 medicines and health foods, ChoA Pharmaceutical is dedicated to improving the health and well-being of individuals worldwide. The company's expertise spans a wide range of therapeutic categories, including products for the digestive, circulatory, and respiratory systems, alongside a comprehensive assortment of vitamins, minerals, nutrients, anti-inflammatories, analgesics, and more. ChoA Pharmaceutical's commitment to quality and innovation is evident in its diverse product offerings, which include tablets, capsules, granules, syrups, solutions, drinkable ampoules, and sachets. Moreover, the company's services extend beyond pharmaceutical manufacturing to include medicine supply and pharmacy management, underscoring its role as a comprehensive healthcare provider. With a global footprint that spans approximately 20 countries, ChoA Pharmaceutical continues to make significant strides in the pharmaceutical industry, driven by its dedication to excellence, research, and development.

Products and Services

• Hepos, Fematin, Vasoclean, Mabis, etc. - These internal ampoule products are part of ChoA Pharmaceutical's extensive range of around 30 specialized solutions catering to various health conditions.
• Drugs for Digestive, Circulatory, and Respiratory Systems - The company provides a variety of pharmaceuticals designed to treat and manage conditions associated with these critical bodily systems.
• Vitamins, Minerals, and Nutrients - ChoA Pharmaceutical offers a wide selection of supplements aimed at supporting overall health and well-being by addressing nutritional deficiencies.
• Anti-Inflammation and Analgesics - These products are formulated to alleviate pain and reduce inflammation, offering relief for various conditions.
• Peripheral Nervous System Medications - The company produces treatments for disorders affecting the peripheral nervous system, showcasing its commitment to addressing a broad spectrum of health issues.
• Gynecologic Diseases Treatments - ChoA Pharmaceutical's portfolio includes specific treatments for gynecological conditions, emphasizing the company's focus on women's health.
• Antibiotics, Antigens, and Anthelmintic - This category encompasses drugs designed to combat infections, diseases, and parasites, highlighting ChoA Pharmaceutical's role in infectious disease control.
• Antitumor Medications - The company is involved in the development and production of antitumor drugs, contributing to the global fight against cancer.
• Other Metabolite Medicines - ChoA Pharmaceutical's range also includes treatments for various metabolic disorders, further illustrating the breadth of its product line.
• Medicine Supply and Pharmacy Management Services - Beyond pharmaceutical manufacturing, the company offers vital services ensuring the efficient supply of medicines and the effective management of pharmacies, thereby enhancing healthcare delivery systems.